• 1. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 4. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 5. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Research Brief on Methyl 2,3-dichloroisonicotinate (CAS: 603124-78-3): Recent Advances and Applications

Methyl 2,3-dichloroisonicotinate (CAS: 603124-78-3) is a key intermediate in the synthesis of various biologically active compounds, particularly in the pharmaceutical and agrochemical industries. Recent studies have highlighted its significance in the development of novel therapeutic agents and crop protection chemicals. This research brief aims to provide an overview of the latest advancements related to this compound, focusing on its synthesis, applications, and potential future directions.

One of the most notable recent developments involves the optimization of synthetic routes for Methyl 2,3-dichloroisonicotinate. Researchers have reported improved yields and reduced environmental impact through the use of catalytic methods and greener solvents. These advancements not only enhance the scalability of production but also align with the growing emphasis on sustainable chemistry in industrial applications.

In the pharmaceutical sector, Methyl 2,3-dichloroisonicotinate has been identified as a crucial building block for the synthesis of kinase inhibitors. A 2023 study demonstrated its utility in the development of novel compounds targeting specific cancer pathways, showing promising results in preclinical models. The compound's unique structural features allow for precise modifications that can enhance drug efficacy and reduce off-target effects.

Agrochemical research has also benefited from innovations involving this compound. Recent patents describe its incorporation into next-generation fungicides with improved activity against resistant strains of plant pathogens. The dichloro-substituted pyridine moiety provides enhanced binding affinity to target enzymes while maintaining favorable environmental profiles.

Analytical characterization techniques for Methyl 2,3-dichloroisonicotinate have seen significant improvements. Advanced spectroscopic methods, including high-resolution mass spectrometry and multidimensional NMR, now enable more accurate quality control and impurity profiling. These developments are particularly important for regulatory compliance and ensuring batch-to-batch consistency in industrial production.

Looking forward, researchers are exploring the potential of Methyl 2,3-dichloroisonicotinate in emerging areas such as PROTAC (proteolysis targeting chimera) technology and covalent inhibitor design. Its versatile chemistry makes it an attractive scaffold for these innovative therapeutic approaches. Additionally, computational modeling studies are providing new insights into structure-activity relationships that may guide future molecular design efforts.

In conclusion, Methyl 2,3-dichloroisonicotinate continues to be a valuable compound in chemical biology and medicinal chemistry research. The recent advancements in its synthesis and applications demonstrate its ongoing relevance in addressing current challenges in drug discovery and crop protection. Future research directions will likely focus on expanding its utility through innovative synthetic methodologies and exploring novel biological targets.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)